Article info

Original research
Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation

Authors

  • Minyu Wang Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Soroor Zadeh Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, AustraliaDepartment of Computing and Information Systems, University of Melbourne VCCC, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Angela Pizzolla Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Kevin Thia Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaCentre for Cancer Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • David E Gyorki Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Grant A McArthur Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, AustraliaDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Richard A Scolyer The University of Sydney, Melanoma Institute Australia, Sydney, New South Wales, AustraliaDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Georgina Long Melanoma Institute Australia, North Sydney, New South Wales, AustraliaDepartment of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • James S Wilmott Melanoma Institute Australia, North Sydney, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Miles C Andrews Department of Medicine, Central Clinical School, Monash University, Clayton, Victoria, Australia PubMed articlesGoogle scholar articles
  • George Au-Yeung Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, AustraliaDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Ali Weppler Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Shahneen Sandhu Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, AustraliaDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Joseph A Trapani Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Melissa J Davis Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, AustraliaDepartment of Computing and Information Systems, University of Melbourne VCCC, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Paul Joseph Neeson Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Paul Joseph Neeson; paul.neeson{at}petermac.org; Dr Melissa J Davis; davis.m{at}wehi.edu.au
View Full Text

Citation

Wang M, Zadeh S, Pizzolla A, et al
Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation

Publication history

  • Accepted March 14, 2022
  • First published April 5, 2022.
Online issue publication 
April 05, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.